CG Oncology, Inc.

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CGON and other ETFs, options, and stocks.

About CGON

CG Oncology, Inc. is a clinical biopharmaceutical company, which engages in the development and commercialization of bladder-sparing therapeutic for patients afflicted with bladder cancer. It offers cretostimogene, a product initially in clinical development for the treatment of patients with Non-Muscle Invasive Bladder Cancer (NMIBC).

CEO

Arthur Kuan

CEOArthur Kuan

Employees

113

Employees113

Headquarters

Irvine, California

HeadquartersIrvine, California

Founded

2010

Founded2010

Employees

113

Employees113

CGON Key Statistics

Market cap

2.87B

Market cap2.87B

Price-Earnings ratio

-21.70

Price-Earnings ratio-21.70

Dividend yield

—

Dividend yield—

Average volume

1.16M

Average volume1.16M

High today

$38.05

High today$38.05

Low today

$36.48

Low today$36.48

Open price

$37.46

Open price$37.46

Volume

607.74K

Volume607.74K

52 Week high

$40.47

52 Week high$40.47

52 Week low

$14.80

52 Week low$14.80

Analyst ratings

100%

of 12 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own CGON. This list is generated using Robinhood data, and it’s not a recommendation.